Primary Record
Ruxolitinib
- In stock
- 8,056 g
- Purity
- 99.0 %
- CAS
- 941678-49-5
Compound Identifiers & Properties
- CAS
- 941678-49-5
- PubChem CID
- 25126798
- SMILES
- C1CCC(C1)[C@@H](CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3
- Canonical SMILES
- N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1
Names & Synonyms
- Ruxolitinib
- 941678-49-5
- Jakafi
- Jakavi
- (R)-ruxolitinib
- INCB018424
- R-Ruxolitinib
- ruxolitinibum
- Ruxolitinib (INCB018424)
- Ruxolitinib phosphate
- S-Ruxolitinib
- Ruxolitinib [INN]
- Ruxolitinib, S-
- INCB-018424
- OPZELURA
- INCB 018424
- INCB18424
- RefChem:6207
- Ruxolitinib (Standard)
- INC424
- Ruxolitinib [USAN:INN]
- ruxolitinib monophosphate
- RUXOLITINIB [MI]
- (Z)-but-2-enedioicacid
- 82S8X8XX8H
- UNII-82S8X8XX8H
- Ruxolitinib (USAN/INN)
- INCB18424,Ruxolitinib
- ruxolitinib (as phosphate)
- RUXOLITINIB [USAN]
- D04LKS
- INCA24
- RUXOLITINIB [VANDF]
- INC-424
- INCB-018424 phosphate
- INCB-18424
- INCB018424 (Ruxolitinib)
- INCB-018424 Salt
- MFCD12031592
- Ruxolitinib (JAK inhibitor)
- RUXOLITINIB [WHO-DD]
- C17H18N6
- cc-189
- CHEBI:66919
- INCB018424(Ruxolitinib)
- INCB018424 SALT
- SCHEMBL171319
- (R)-Ruxolitinib (>90%)
- DTXSID10240930
- INC 424
- GTPL5688
- INCB018424 - Ruxolitinib
- orb1307364
- (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
- CHEMBL1789941
- INCB-18424 PHOSPHATE
- INCB018424 PHOSPHATE
- SCHEMBL16546708
- SCHEMBL29349794
- HSDB 8259
- DTXCID40163421
- L01XE18
- SYN1120
- HFNKQEVNSGCOJV-OAHLLOKOSA-N
- Oral JAK Inhibitor INCB18424
- GLXC-90091
- HMS6018A14
- INCB 18424
- Ruxolitinib, 941678-49-5
- ACT06813
- AMY24152
- AOB87783
- EX-A1670
- KS-000006SM
- ABP000827
- ABP000833
- BDBM50355501
- EBC-17053
- HY-50856R
- NSC763371
- NSC800874
- s1378
- ZINC43207851
- AKOS016842401
- ACN-031567
- BCP9000784
- CCG-264889
- CS-0864
- CS-T-61211
- DB08877
- FR27771
- INCB018424(Ruxolitinib)/Ruxolitinib
- NSC-763371
- NSC-800874
- SDCCGSBI-0654261.P002
- Ruxolitinib, 98% - 100MG 100mg
- NCGC00244253-01
- NCGC00244253-02
- NCGC00244253-11
- NCGC00244253-12
- NCGC00244253-23
- 1-(2-adamantyl)-3-(2,3,4-trifluorophenyl)urea
- AC-24280
- AC-38227
- AK-48608
- AS-18619
- BP-44052
- BR-48608
- HY-50856
- QC-11806
- AJ-108289
- ST2407566
- (3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile
- A3012
- A3781
- FT-0674485
- W9658
- INCB018424 /INCB-018424
- J2.740.099J
- A11041
- A14955
- A23578
- D09959
- Q-4578
- AB01565782_02
- EN300-18772174
- Q7383611
- (3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile
- BRD-K53972329-001-02-1
- BRD-K53972329-001-03-9
- BRD-K53972329-001-07-0
- (R)-3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile (Synonyms:Ruxolitinib)
- 1H-Pyrazole-1-propanenitrile, beta-cyclopentyl-4-(7H-
- (3R)-3-cyclopentyl-3-(4-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}-1H-pyrazol-1-yl)propanenitrile
- B0084-156872
- 1160597-27-2
- (betaR)-beta-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile
- (3R)-3-CYCLOPENTYL-3-(4-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PYRAZOL-1-YL)PROPANENITRILE
- 1092939-15-5
- 1092939-17-7
- 1H-Pyrazole-1-propanenitrile, beta-cyclopentyl-4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-,(betaR)-
- (?-R)-?-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile
- (|_R)-|_-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile
- (3R)-3-cyclopentyl-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)propanenitrile
- (3R)-3-cyclopentyl-3-(4-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}pyrazol-1-yl)propanenitrile
- (3R)-3-cyclopentyl-3-[4-(1H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile
- (betaR)-beta-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidine-4-yl)-1H-pyrazole-1-propanenitrile
- (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H -pyrazol-1-yl)-3-cyclopentylpropanenitrile
- ?-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-(?R)-1H-pyrazole-1-propanenitrile
- |A-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-(|AR)-1H-pyrazole-1-propanenitrile
- 3-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-(beta-R)-1H-pyrazole-1-propanenitrile
- 3R)-3-cyclopentyl-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)pyrazol-1-yl)propanenitrile
- A-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-(AR)-1H-pyrazole-1-propanenitrile
- (3R)-3-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidine-4-yl)-1H-pyrazole-1-yl]propanenitrile
- (R)-3-[4-(7H-Pyrrolo[2,3-d]pyrimidine-4-yl)-1H-pyrazole-1-yl]-3-cyclopentylpropanenitrile
- (ssR)-ss-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile; (3R)-3-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile; (ssR)-ss-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile; INC 424; INCB 018424; Ruxolitinib
- 107-728-9
- 1513883-39-0
- 1H-PYRAZOLE-1-PROPANENITRILE, .BETA.-CYCLOPENTYL-4-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)-, (.BETA.R)-
- 941685-37-6
- RXT